Viatris (VTRS)

[Fortune 500]

IIMO, It would be terrific if Mylan acquired a company such as Adxs so their students could be prepared for immunology . Mylan obviously can produce monoclonal antibody products . I expect we will see more biosimilars in the billions of dollars being approved this year as we saw in 2018. Since they are part of a Pittsburg school of pharmacy , it would be fitting for Mylan to grab a compsny like Adxs while it is vulnerable.
After all , Mylan’s slogan has always been .. quality is our blood line . It ‘s time to cure cancer . Let’s get to the next new thing now ! The moniclonals took way too long . Let’s get these immunological products on the market and then Mylan can be the acquirer . Let Teva make the epipen. Tired of reading about epipens. Necessary because we need immunotherapy! Organic chemicals are creating the allergens .